TWST Twist Bioscience RESULTS: Q3, Q3 REV $118.4M vs. EST $114.5M, Q3 EPS $-0.56, Twist Bioscience Earnings Notes:, Outlook FY REV $456-457M
TWST Twist Bioscience RESULTS: Q3, Q3 REV $118.4M vs. EST $114.5M, Q3 EPS $-0.56, Twist Bioscience Earnings Notes:, Outlook FY REV $456-457M, Outlook Q4 total REV of approximately $123M to $124M, Outlook Q4 to achieve ADJ EBITDA breakeven, Outlook FY gross margin to be above 52%
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.